
|Videos|July 23, 2013
Episode 6 - Addressing the Gaps in Care for Hemophilia Patients
Advertisement
Delivering the optimal care to patients with hemophilia is often a challenge, both clinically and financially. According to Patrick Fogarty, MD, the individuals who are best fit to execute treatment guidelines are those who practice at specialty hemophilia treatment centers, as they are able to provide on-site multidisciplinary, comprehensive care.
However, the panelists conclude that there are still gaps in current treatment guidelines that require addressing. In an effort to provide the best of care to all patients with hemophilia, regardless of geography, strategies such as home care, satellite clinics, and increased patient education have been implemented into contemporary treatment paradigms.
Advertisement
Related to this article

Panelists concurred that precision medicine can serve to exacerbate care inequality if not everyone can access these therapeutics.

Employer diabetes guide; Camden psychedelic therapy input; CRC after EMR; rural HFrEF care; JAMA obesity report.

This article analyzes gaps in US biosimilar development, quantifies market opportunities, and proposes policy and economic solutions to improve cost savings and patient access.

An employer coalition's new guide outlines how workplaces can prevent and manage diabetes, from benefit design to accommodations.

New York hepatitis B experts say screening gaps and weekly monitoring demands could limit who benefits from the first functional cure therapy.

San Francisco experts say earlier IgA nephropathy and FSGS detection depends on primary care education and care coordinators.

Earlier MASH fibrosis detection is more urgent now that treatments exist, and automating FIB-4 in EHRs could help primary care, says Rohit Loomba, MD.
Advertisement
Advertisement



















